Eiger Biopharmaceuticals Statistics
Total Valuation
EIGRQ has a market cap or net worth of $2.55 million. The enterprise value is $18.32 million.
| Market Cap | 2.55M |
| Enterprise Value | 18.32M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
EIGRQ has 1.48 million shares outstanding. The number of shares has increased by 6.39% in one year.
| Shares Outstanding | 1.48M |
| Shares Change (YoY) | +6.39% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 11.80% |
| Owned by Institutions (%) | 43.86% |
| Float | 1.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| Forward PS | 0.13 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71
| Current Ratio | 0.71 |
| Quick Ratio | 0.51 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.71 |
Financial Efficiency
Return on equity (ROE) is -869.80% and return on invested capital (ROIC) is -268.41%.
| Return on Equity (ROE) | -869.80% |
| Return on Assets (ROA) | -112.70% |
| Return on Capital (ROIC) | -268.41% |
| Revenue Per Employee | $281,661 |
| Profits Per Employee | -$1.34M |
| Employee Count | 56 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.01 |
Taxes
In the past 12 months, EIGRQ has paid $6,000 in taxes.
| Income Tax | 6,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.79% in the last 52 weeks. The beta is 1.85, so EIGRQ's price volatility has been higher than the market average.
| Beta (1Y) | 1.85 |
| 52-Week Price Change | -90.79% |
| 50-Day Moving Average | 4.32 |
| 200-Day Moving Average | 10.22 |
| Relative Strength Index (RSI) | 39.46 |
| Average Volume (30 Days) | n/a |
Short Selling Information
The latest short interest is 29,810, so 2.02% of the outstanding shares have been sold short.
| Short Interest | 29,810 |
| Short Previous Month | 33,594 |
| Short % of Shares Out | 2.02% |
| Short % of Float | 2.34% |
| Short Ratio (days to cover) | 3.72 |
Income Statement
In the last 12 months, EIGRQ had revenue of $15.77 million and -$74.96 million in losses. Loss per share was -$50.78.
| Revenue | 15.77M |
| Gross Profit | 15.75M |
| Operating Income | -71.79M |
| Pretax Income | -74.96M |
| Net Income | -74.96M |
| EBITDA | -68.74M |
| EBIT | -69.49M |
| Loss Per Share | -$50.78 |
Balance Sheet
The company has $25.44 million in cash and $41.20 million in debt, giving a net cash position of -$15.76 million or -$10.68 per share.
| Cash & Cash Equivalents | 25.44M |
| Total Debt | 41.20M |
| Net Cash | -15.76M |
| Net Cash Per Share | -$10.68 |
| Equity / Book Value | -14.46M |
| Book Value Per Share | -9.79 |
| Working Capital | -15.45M |
Cash Flow
In the last 12 months, operating cash flow was -$74.55 million and capital expenditures -$234,000, giving a free cash flow of -$74.78 million.
| Operating Cash Flow | -74.55M |
| Capital Expenditures | -234,000 |
| Free Cash Flow | -74.78M |
| FCF Per Share | -$50.66 |
Margins
Gross margin is 99.85%, with operating and profit margins of -455.12% and -475.26%.
| Gross Margin | 99.85% |
| Operating Margin | -455.12% |
| Pretax Margin | -475.22% |
| Profit Margin | -475.26% |
| EBITDA Margin | -435.81% |
| EBIT Margin | -440.57% |
| FCF Margin | -474.11% |
Dividends & Yields
EIGRQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.39% |
| Shareholder Yield | -6.39% |
| Earnings Yield | -2,937.28% |
| FCF Yield | -2,930.19% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 8, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jan 8, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
EIGRQ has an Altman Z-Score of -24.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -24.42 |
| Piotroski F-Score | 3 |